Neoadjuvant Docetaxel in Locally Advanced Breast Cancer
- 1 March 2003
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 79 (1) , 19-24
- https://doi.org/10.1023/a:1024333725148
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With DocetaxelJournal of Clinical Oncology, 2002
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJournal of Clinical Oncology, 2001
- Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast GroupEuropean Journal Of Cancer, 1999
- Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing ChemotherapyJournal of Clinical Oncology, 1999
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Multidrug Resistance in Breast Cancer--Is the Jury in Yet?JNCI Journal of the National Cancer Institute, 1997
- Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional SignificanceJNCI Journal of the National Cancer Institute, 1997
- Cellular resistance to anthracyclinesGeneral Pharmacology: The Vascular System, 1996
- Anthracycline resistance in breast cancer: Clinical applications of current knowledgeEuropean Journal Of Cancer, 1995